MAP2K1 and melanoma: In another report, CRISPR RNA-guided deaminase technology was combined with CROP-seq (CRISPR droplet sequencing) technology to introduce mutations in 3 genes of the MAPK pathway in A375 melanoma cells, namely NRAS, KRAS and MAP2K1 (MEK1) [87].